Structures by: Codding P. W.
Total: 30
C17H25N1O3,H1Cl1
C17H25N1O3,H1Cl1
Acta Crystallographica Section B (1995) 51, 5 803-810
a=16.7630(10)Å b=10.1619(7)Å c=21.503(2)Å
α=90° β=97.758(6)° γ=90°
C22H25N1O5,H1Cl1
C22H25N1O5,H1Cl1
Acta Crystallographica Section B (1995) 51, 5 803-810
a=15.684(2)Å b=6.4228(7)Å c=22.249(2)Å
α=90° β=109.656(9)° γ=90°
C22H25N1O4,C2H2O4
C22H25N1O4,C2H2O4
Acta Crystallographica Section B (1995) 51, 5 803-810
a=8.3651(3)Å b=25.6280(10)Å c=5.5890(3)Å
α=95.447(4)° β=106.614(4)° γ=82.653(4)°
C8H4N4O6
C8H4N4O6
Acta Crystallographica Section B (1996) 52, 3 487-499
a=8.4668(3)Å b=8.5533(4)Å c=12.4657(6)Å
α=90° β=90.341(3)° γ=90°
C8H7N3O5
C8H7N3O5
Acta Crystallographica Section B (1996) 52, 3 487-499
a=7.4744(9)Å b=11.9265(9)Å c=10.4910(5)Å
α=90° β=97.513(7)° γ=90°
C8H4N4O6
C8H4N4O6
Acta Crystallographica Section B (1996) 52, 3 487-499
a=6.9774(6)Å b=13.0830(10)Å c=20.4010(10)Å
α=90° β=90° γ=90°
C8H4Cl2N2O2
C8H4Cl2N2O2
Acta Crystallographica Section B (1996) 52, 3 487-499
a=7.2066(5)Å b=8.4502(5)Å c=14.4709(7)Å
α=90° β=99.707(5)° γ=90°
C11H11Cl2N3O3
C11H11Cl2N3O3
Acta Crystallographica Section B (1996) 52, 3 487-499
a=6.1501(4)Å b=8.3787(4)Å c=13.7356(10)Å
α=107.407(5)° β=99.304(6)° γ=95.032(4)°
C21H15N3O2
C21H15N3O2
Acta Crystallographica Section B (1993) 49, 4 719-726
a=12.1646(5)Å b=5.5988(2)Å c=12.389(2)Å
α=90.° β=90.470(10)° γ=90.°
C21H14ClN3O2
C21H14ClN3O2
Acta Crystallographica Section B (1993) 49, 4 719-726
a=10.9354(6)Å b=14.5020(10)Å c=13.0190(10)Å
α=90.° β=114.481(4)° γ=90.°
C22H17N3O2
C22H17N3O2
Acta Crystallographica Section B (1993) 49, 4 719-726
a=5.618(2)Å b=30.329(7)Å c=10.456(4)Å
α=90.° β=98.21(2)° γ=90.°
C23H18N2O2
C23H18N2O2
Acta Crystallographica Section B (1993) 49, 4 719-726
a=10.2078(4)Å b=10.2370(10)Å c=35.676(3)Å
α=90.° β=90.° γ=90.°
1-(2-Pyridyl)-8H-pyrrolo[2,1-c]-s-triazolo[4,3-a][1,4]benzodiazepinium chloride
C18H14N51,Cl1
Acta Crystallographica Section E (2001) 57, 2 o122-o124
a=8.7856(5)Å b=8.2058(5)Å c=22.990(2)Å
α=90.00° β=95.513(6)° γ=90.00°
8-Oxa-1-aza-7-phenylbicyclo[5.2.1]decane-9,10-dione
C14H15NO3
Acta Crystallographica Section E (2001) 57, 5 o406-o407
a=6.7112(8)Å b=10.4414(8)Å c=17.687(2)Å
α=90.00° β=90.00° γ=90.00°
Α-[(diphenylmethoxy)methyl]-2,5-dimethyl-1-pyrrolidineethanol
C22H29NO2
Acta Crystallographica Section E (2001) 57, 6 o490-o491
a=8.3588(4)Å b=10.6774(4)Å c=12.5709(5)Å
α=99.033(3)° β=108.701(4)° γ=99.057(3)°
PK11195
C21H21ClN2O
Acta Crystallographica Section E (2001) 57, 5 o389-o391
a=10.365(2)Å b=15.529(4)Å c=11.767(3)Å
α=90.00° β=93.33(2)° γ=90.00°
9-(Cyclohexylmethyl)-6-(dimethylamino)-9H-purine
C14H21N5
Acta Crystallographica Section E (2001) 57, 4 o332-o334
a=5.7702(5)Å b=11.3210(10)Å c=22.3900(10)Å
α=90.00° β=91.470(10)° γ=90.00°
C18H16N2O2
C18H16N2O2
Acta Crystallographica Section C (1992) 48, 8 1516-1518
a=8.4118(2)Å b=11.9934(4)Å c=7.9901(4)Å
α=83.493(3)° β=114.946(3)° γ=101.598(3)°
C17H10ClN3
C17H10ClN3
Acta Crystallographica Section C (1992) 48, 2 382-384
a=8.3291(5)Å b=8.3291(5)Å c=17.1142(14)Å
α=90° β=90° γ=120.0000°
5,7-dichlorokynurenic acid hydrate
C10H5Cl2NO3,H2O
Acta Crystallographica Section C (1997) 53, 6 739-742
a=12.5928(7)Å b=10.6943(10)Å c=16.0674(5)Å
α=90.00° β=93.168(3)° γ=90.00°
C24H32N4O3
C24H32N4O3
Acta Crystallographica Section C (1991) 47, 5 1038-1040
a=15.7400(10)Å b=17.279(3)Å c=8.757(2)Å
α=90° β=101.670(10)° γ=90°
Methyl 4-(N-benzylamino)-6-methyl-2-oxo-3-cyclohexene-1-oate
C16H19NO3
Acta Crystallographica Section C (1993) 49, 11 2045-2046
a=8.9562(4)Å b=7.1033(3)Å c=22.7440(10)Å
α=90.00° β=90.017(4)° γ=90.00°
O-cyanophenol
C7H5NO
Acta Crystallographica Section C (1996) 52, 12 3171-3173
a=7.4614(4)Å b=16.5571(13)Å c=20.6129(14)Å
α=90.00° β=90.00° γ=90.00°
Cyclo-glycyl-L-phenylglycine
C10H10N2O2,0.25H2O
Acta Crystallographica Section C (1994) 50, 4 565-569
a=37.462(2)Å b=6.2017(3)Å c=8.1843(4)Å
α=90.00° β=98.891(4)° γ=90.00°
Cyclo-L-alanyl-D-phenylglycine
C11H12N2O2
Acta Crystallographica Section C (1994) 50, 4 565-569
a=5.0084(6)Å b=20.367(3)Å c=5.2057(5)Å
α=90.00° β=105.198(8)° γ=90.00°
Hippuryl-L-Histidyl-L-Leucine
C21H27N5O5,5H2O
Acta Crystallographica Section C (1996) 52, 5 1300-1302
a=10.055(2)Å b=14.974(4)Å c=17.825(5)Å
α=90.00° β=90.00° γ=90.00°
(11R-trans)-11-ethylthio-1,2,3,10,11,11a-hexahydro--5H-pyrrolo[2,1-c][1,4] benzodiazepin-5-one
C14H18N2OS
Acta Crystallographica Section C (1997) 53, 9 1288-1290
a=8.9850(8)Å b=8.9850(8)Å c=17.1652(10)Å
α=90.00° β=90.00° γ=90.00°
2,6,7-Trimethyl-3-(2'-pyridine)-3,4-dihydro-4-oxoquinazoline-8-carboxylic Acid
C17H15N3O3
Acta Crystallographica Section C (1997) 53, 9 1291-1293
a=12.9397(12)Å b=4.9019(4)Å c=23.1800(3)Å
α=90.00° β=90.703(9)° γ=90.00°
Methyl β-carboline-3-carboxylate.
C13H10N2O2
Acta Crystallographica Section C (2001) 57, 6 728-729
a=9.6550(5)Å b=20.8077(8)Å c=11.0793(5)Å
α=90.00° β=102.388(5)° γ=90.00°
C21H14ClN3O2
C21H14ClN3O2
Acta Crystallographica Section B (1993) 49, 4 719-726
a=13.9347(7)Å b=9.6794(6)Å c=25.9620(10)Å
α=90.° β=90.° γ=90.°